Who are the key players in US Biocatalysis & Biocatalysts Market industry?

Key players in the US Biocatalysis & Biocatalysts market include Novozymes, DuPont (IFF), Codexis, BASF SE, and Amano Enzyme. These companies lead in enzyme development, innovative bioprocesses, and applications across pharmaceuticals, food & beverage, and biofuels, driving technological advancements and market growth with robust R&D capabilities.

What is the US Biocatalysis & Biocatalysts Market growth?

The US Biocatalysis & Biocatalysts market has seen significant growth, with increased demand for sustainable processing in pharmaceuticals and specialty chemicals. For instance, Novozymes reported double-digit sales growth in 2023, driven by rising adoption of enzyme-based solutions in industrial biotechnology and green chemistry initiatives.

Which segment accounted for the largest US Biocatalysis & Biocatalysts Market share?

The pharmaceutical application segment accounted for the largest share of the US Biocatalysis & Biocatalysts market. This dominance is attributed to the increasing use of biocatalysts in drug synthesis, offering higher specificity and efficiency. Major pharmaceutical companies utilize biocatalysis for green and cost-effective production methods.

What are the factors driving the US Biocatalysis & Biocatalysts Market?

Key drivers include the growing demand for sustainable and eco-friendly processes in sectors like pharmaceuticals and biofuels. For example, DuPont’s introduction of enzyme solutions for bio-based industrial applications showcases how environmental regulations and demand for green chemistry are boosting market growth.

Which type accounted for the largest US Biocatalysis & Biocatalysts Market share?

Hydrolases held the largest share of the US Biocatalysis & Biocatalysts market. Their extensive use in pharmaceuticals, food, and detergent industries due to their efficacy in catalyzing biochemical reactions makes them a dominant enzyme type. Leading companies are continuously developing advanced hydrolases for diverse industrial use.

Home Chemical & Material

US Biocatalysis & Biocatalysts Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: US Biocatalysis & Biocatalysts Market
Brand: Bussiness Insights

US Biocatalysis & Biocatalysts Market: by Type (Oxidoreductases, Transferases, Hydrolases, Lyases, Isomerases, Ligases), Application (Pharmaceuticals, Food & Beverages, Biofuels, Agriculture, Detergents, Others), Distribution Channels (Direct Sales, Distributors/Wholesalers, Online Retail, Specialty Stores, Research Institutes, Others), Technology (Enzyme Engineering, Directed Evolution, Immobilized Enzymes, Whole Cell Biocatalysis, High-Throughput Screening, Computational Biocatalysis), Organization Size (Small, Medium, Large) and By US Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 23-07-2025 | Format: PDF | Report ID:1966

US Biocatalysis & Biocatalysts Market Forecast (2025-2035)

The US biocatalysis and biocatalysts market is experiencing rapid transformation, powered by advancements in enzyme engineering, sustainability drives in industrial processing, and increased deployment in pharmaceuticals and biofuels. Companies are leveraging technological innovation to expand enzymatic applications across sectors, optimize production processes, and meet stringent regulatory standards for green chemistry. The market's expansion is also propelled by growing demand for bio-based products and collaborative ventures among leading enzyme firms and biotech startups.

Latest Market Dynamics

Key Drivers

Surging demand for eco-friendly and sustainable industrial processes, with DSM innovating customized biocatalysts for green chemistry.
Technological advancements in enzyme engineering, notably Codexis

In 2025, Oxidoreductases dominate the US biocatalysts market, driven by their extensive use in pharmaceutical synthesis and specialty chemicals. Transferases hold a significant share due to their role in agricultural and food processing, while Hydrolases follow closely, benefiting from robust applications in biofuel production and detergents. The sector continues to see growth in Lyases, Isomerases, and Ligases, but Oxidoreductases, Transferases, and Hydrolases together represent over 75% of market share thanks to established demand across industries.

Pharmaceuticals represent the largest segment in the US biocatalysis market for 2025, accounting for a major portion of enzymatic demand due to drug production and green chemistry efforts. Food & Beverages maintain strong adoption of biocatalysts to improve yields and product quality, particularly in dairy and baking. The Biofuels sector is another significant application, capitalizing on enzyme innovation for the conversion of renewable feedstocks. Together, these three end-uses capture the highest shares, reflecting strong investments and rapid technology adoption.

The US biocatalysis and biocatalysts market is set for significant revenue growth, with market value expected to rise from $1,200 Million in 2020 to an estimated $2,950 Million by 2035. Growth is underpinned by expansion in bio-pharmaceutical, green chemistry, and sustainable fuels segments. Notably, revenue acceleration is anticipated post-2025, aligning with commercialization of new enzyme technologies and increased regulatory mandates for sustainable processes.

Year-on-year (YOY) growth in the US biocatalysis market remains steady between 4.5% to 6.2% from 2020 to 2035, with a projected peak growth phase between 2025 and 2030. This is largely due to the introduction of advanced biocatalyst technologies and growing industrial uptake across pharmaceuticals and renewable biofuels. Although growth stabilizes slightly post-2030 as the market matures, robust expansion is projected long-term.

The Midwest leads the US biocatalysis & biocatalysts market by region in 2025, attributed to concentrated biofuel and agro-industrial activity. The Northeast follows, propelled by pharmaceutical and life sciences clusters. Western states increasingly contribute through growing biotech hubs and green chemistry initiatives. This regional split reflects diversified end-user bases and varying levels of industrialization and innovation across the US.

Novozymes leads the US biocatalysts market in 2025 with a strong market share, driven by consistent innovation and strategic collaborations. Codexis and BASF also command substantial shares due to their focus on advanced enzyme engineering and process efficiencies. The top three players collectively cover over half the market, reinforcing their leadership through R&D and supply chain optimization.

In 2025, pharmaceutical manufacturers are the top buyers of biocatalysts in the US, driven by escalating demand for efficient, selective synthesis methods. Food & beverage companies rank second owing to widespread adoption for product enhancement and process efficiency. Biofuel producers are a significant third, leveraging cutting-edge enzymes for sustainable fuel generation. These segments collectively underpin substantial market demand and innovation.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	Revenue (USD Million)
Regions	Midwest, Northeast, West, South
Segments	By Type (Oxidoreductases, Transferases, Hydrolases, Lyases, Isomerases, Ligases), By Application (Pharmaceuticals, Food & Beverages, Biofuels, Agriculture, Detergents, Others), By Distribution Channels (Direct Sales, Distributors/Wholesalers, Online Retail, Specialty Stores, Research Institutes, Others), By Technology (Enzyme Engineering, Directed Evolution, Immobilized Enzymes, Whole Cell Biocatalysis, High-Throughput Screening, Computational Biocatalysis), By Organization Size (Small, Medium, Large)
Players	Novozymes, Codexis, BASF, DSM, DuPont, Amano Enzyme, Chr. Hansen Holding, Danisco, Kerry Group, AB Enzymes, Advanced Enzyme Technologies, Biocatalysts Ltd, Prozomix, Enzyme Development Corporation, Royal DSM

Novozymes formed a joint venture with an American biofuels company for next-gen enzyme solutions (June 2024).
Codexis launched its new AI-accelerated enzyme discovery platform, Enhanzym, targeting pharma clients (July 2024).
DSM introduced a tailored suite of biocatalysts for precision fermentation in food applications (August 2024).
BASF expanded its US enzyme production capacity with a new Texas facility focused on sustainable chemicals (September 2024).
DuPont received FDA approval for a novel enzyme blend in pharmaceutical manufacturing (September 2024).

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

US Biocatalysis & Biocatalysts Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

US Biocatalysis & Biocatalysts Market Forecast (2025-2035)

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

US Biocatalysis & Biocatalysts Market Share by Type, 2025

US Biocatalysis & Biocatalysts Market Share by Application, 2025

US Biocatalysis & Biocatalysts Market Revenue (USD Million), 2020-2035

US Biocatalysis & Biocatalysts Market YOY Growth (%), 2020-2035

US Biocatalysis & Biocatalysts Market Share by Region, 2025

US Biocatalysis & Biocatalysts Market Share by Major Players, 2025

US Biocatalysis & Biocatalysts Market Share by Major Buyer Segments, 2025

Study Coverage

Key Recent Developments

Frequently asked questions